Showing results (141-150 of 356) with videos related to

Sort By:
Pageof 36
Human Immunology|October 1, 1983
Isolation of heavy chain class switch variants of a monoclonal anti-DC1 hybridoma cell line: effective conversion of noncytotoxic IgG1 antibodies to cytotoxic IgG2 antibodiesP Parham, T J Kipps, F E Ward, et al.
The Journal of Experimental Medicine|December 1, 1996
Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-gamma signaling complex in human natural killer (NK) cellsN M Valiante, J H Phillips, L L Lanier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1994
Peptides corresponding to the CD8 and CD4 binding domains of HLA molecules block T lymphocyte immune responses in vitroC Clayberger, S C Lyu, R DeKruyff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1987
Multiple genetic mechanisms have contributed to the generation of the HLA-A2/A28 family of class I MHC moleculesN Holmes, P Ennis, A M Wan, et al.
Nature|March 12, 1987
Clathrin light chains contain brain-specific insertion sequences and a region of homology with intermediate filamentsA P Jackson, H F Seow, N Holmes, et al.
Tissue Antigens|January 6, 2001
Discovery of two novel variants of KIR2DS5 reveals this gene to be a common component of human KIR 'B' haplotypesC Vilches, M J Pando, R Rajalingam, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2000
MHC I-dependent antigen presentation is inhibited by poliovirus protein 3AS B Deitz, D A Dodd, S Cooper, et al.
The Journal of Experimental Medicine|October 1, 1993
Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell typeV Litwin, J Gumperz, P Parham, et al.
Proceedings. Biological Sciences|May 22, 1991
CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68.1V Cerundolo, A G Tse, R D Salter, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 14, 2011
Cervical cancer prevention in low- and middle-income countries: feasible, affordable, essentialVikrant V Sahasrabuddhe, Groesbeck P Parham, Mulindi H Mwanahamuntu, et al.
Pageof 36